Cambridge, United Kingdom · Founded 2015 · Privately Held (backing)
Operator of a biotechnology and drug discovery company intended to develop small molecule therapies for RNA modification enzymes for use in the treatment of cancer and other immune diseases. STORM Therapeutics is based in Cambridge, United Kingdom and was founded in 2015. Its last reported valuation was $90.3 million in Dec 2022. It has raised $172 million.
Last reported valuation
$90.3M
Oct 2026
Priced at
—
Total raised
$172.2M
Last round
—
Cap table — not yet on record
STORM Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of STORM Therapeutics with a free account
·The complete investor list: 12 names
·Watch STORM Therapeutics: the Monday email on marks, rounds and moves
